文献速递癫痫

抗癫痫药物母婴结局与神经发育效应研究中母乳喂养的启动与持续时间

Initiation and Duration of Breastfeeding in the Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs Study.
PubMed 文献 · Neurology · 2023-11-27

该前瞻性多中心观察性美国队列研究纳入351例癫痫孕妇和105例对照孕妇,比较母乳喂养启动与持续时间。癫痫组启动母乳喂养者占74.8%,对照组占88.8%,未校正分析差异显著(OR 0.4,95%CI 0.2-0.7,p=0.004),校正母亲智商与教育程度后差异未达统计学显著(OR 0.5,95%CI 0.2-1.0,p=0.051)。两组母乳喂养持续时间无显著差异(中位8.5个月 vs 9.9个月,p=0.793)。

要点

  • 癫痫母亲启动母乳喂养的比例低于对照,但校正智商与教育后差异未达统计学显著。
  • 已启动母乳喂养的母亲中,癫痫组与对照组持续时间无显著差异。
  • 孕期全面性强直-阵挛发作及所有伴意识受损发作与较低母乳喂养启动相关。

核心结论

  • 癫痫母亲启动母乳喂养的可能性低于对照母亲,但控制母亲智商和教育水平后该差异未达统计学显著。
  • 一旦启动母乳喂养,癫痫母亲与无癫痫母亲的持续时间无差异。
  • 癫痫母亲的发作控制与母乳喂养启动和持续时间相关。

研究设计与样本

  • 抗癫痫药物母婴结局与神经发育效应研究为前瞻性、多中心、观察性美国队列研究。
  • 纳入2012年12月19日至2016年2月11日期间入组的14-45岁怀孕个体,包括癫痫组和无癫痫对照组。
  • 排除标准包括智商低于70及入组时孕周大于20周。
  • 通过电子日记和研究访视评估至产后2年的母乳喂养情况。
  • 采用未校正和校正逻辑回归模型比较两队列启动母乳喂养的比值比,采用对数秩检验比较母乳喂养持续时间。

主要发现

  • 共纳入351例癫痫孕妇和105例对照孕妇;母乳喂养数据可获取于325例癫痫母亲和98例对照。
  • 两队列人口学特征除种族外相似(p=0.008);癫痫母亲中84.9%为白人,对照中71.4%为白人。
  • 癫痫母亲平均智商低于对照(97.7 vs 104.2,p<0.001)。
  • 癫痫母亲启动母乳喂养者占74.8%,对照占88.8%;未校正逻辑回归差异显著(OR 0.4,95%CI 0.2-0.7,p=0.004),校正模型未达统计学显著(OR 0.5,95%CI 0.2-1.0,p=0.051)。
  • 与母乳喂养相关的因素为母亲较高教育水平和较高智商。

关键数值与推荐

  • 癫痫母亲与对照母亲母乳喂养持续时间无差异(中位8.5个月 vs 9.9个月,p=0.793)。
  • 癫痫母亲中,孕期全面性强直-阵挛发作与较低母乳喂养启动相关(OR 0.4,95%CI 0.2-0.8,p=0.013)。
  • 癫痫母亲中,孕期所有伴意识受损发作与较低母乳喂养启动相关(OR 0.4,95%CI 0.2-0.8,p=0.003)。
  • 围产期任何发作与更短母乳喂养持续时间相关(中位6个月 vs 9.7个月,p=0.040)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Breastfeeding has important health benefits for both mother and child. We characterize breastfeeding initiation and duration in mothers with epilepsy relative to control mothers in a large prospective cohort. METHODS: The Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs study is a prospective, multicenter observational, US cohort study. Pregnant individuals with and without epilepsy, aged 14-45 years, were enrolled between December 19, 2012, and February 11, 2016. Exclusion criteria included intelligence quotient (IQ) <70, and gestational age >20 weeks at enrollment. Breastfeeding was assessed through electronic diary and at study visits until 2 years postpartum. Odds of initiating breastfeeding was compared between cohorts using unadjusted and adjusted logistic regression models. Duration of breastfeeding was compared between cohorts using the log-rank test. RESULTS: Three hundred fifty-one pregnant individuals with epilepsy and 105 pregnant controls were enrolled. Breastfeeding data were available for 325 mothers with epilepsy and 98 controls. Study cohorts were similar demographically except race (p = 0.008); 84.9% of mothers with epilepsy and 71.4% of controls were White. The mean IQ was lower in mothers with epilepsy compared with that in controls (97.7 vs 104.2, p < 0.001). Breastfeeding was initiated by 74.8% mothers with epilepsy and 88.8% controls; this difference was significant in unadjusted logistic regression (odds ratio [OR] 0.4 [95% CI 0.2, 0.7], p = 0.004), but not in adjusted model (OR 0.5 [95% CI 0.2, 1.0], p = 0.051). Factors associated with breastfeeding were higher maternal education and IQ. There was no difference in duration of breastfeeding between mothers with and without epilepsy (median duration 8.5 months vs 9.9 months, p = 0.793). Among mothers with epilepsy, both convulsive seizures and all seizures that impair awareness during pregnancy were associated with lower breastfeeding initiation (OR 0.4 [95% CI 0.2, 0.8], p = 0.013) and (OR 0.4 [95% CI 0.2, 0.8], p = 0.003, respectively). Any peripartum seizures were associated with shorter breastfeeding duration (median 6 months vs 9.7 months, [p = 0.040]). DISCUSSION: Mothers with epilepsy were less likely to initiate breastfeeding compared with controls; however, this difference was not significant when controlling for maternal IQ and education level. Continuation of breastfeeding once initiated was not different between mothers with and without epilepsy. Seizure control was associated with breastfeeding initiation and duration in mothers with epilepsy. TRIAL REGISTRATION INFORMATION: ClinicalTrials.gov identifier NCT01730170.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Gerard EE, Meador KJ, Robalino CP, et al. Initiation and Duration of Breastfeeding in the Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs Study. Neurology. 2023. PMID: 37816636. doi:10.1212/WNL.0000000000207812

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。